These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 818363)

  • 1. Development of a stable sublingual nitroglycerin tablet II: formulation and evaluation of tablets containing povidone.
    Fung HL; Yap SK; Rhodes CT
    J Pharm Sci; 1976 Apr; 65(4):558-60. PubMed ID: 818363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of nilvadipine solid dispersion to tablet formulation and manufacturing using crospovidone and methylcellulose as dispersion carriers.
    Hirasawa N; Ishise S; Miyata H; Danjo K
    Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):244-7. PubMed ID: 14758011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of some materials as dry binders for direct compression in tablet manufacture. Part 7: Formulation and evaluation of ascorbic acid and phenobarbitone tablets.
    Asker AF; Saied KM; Abdel-Khalek MM
    Pharmazie; 1975 Jul; 30(7):466-70. PubMed ID: 1178765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy polysaccharide as a novel superdisintegrant in sildenafil citrate sublingual tablets: preparation, characterization, and in vivo evaluation.
    Hosny KM; Mosli HA; Hassan AH
    Drug Des Devel Ther; 2015; 9():465-72. PubMed ID: 25624751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Development of a stable sublingual nitroglycerin tablet I: interaction of nitroglycerin with selected macromolecules.
    Fung HL; Yap SK; Rhodes CT
    J Pharm Sci; 1974 Nov; 63(11):1810-2. PubMed ID: 4214916
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid determination of nitroglycerin volatility using thermogravimetric analysis.
    Gucluyildiz H; Goodhart FW; Ninger FC
    J Pharm Sci; 1977 Feb; 66(2):265-6. PubMed ID: 402469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules.
    Mehta S; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2012 Jan; 422(1-2):310-7. PubMed ID: 22101283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual nitroglycerin. II. In vitro and in vivo availability of Nitrostat and Nitrobaat tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):254-8. PubMed ID: 3145488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of two direct compression lactose grades for pyridoxine hydrochloride tablets.
    Aly SA; Udeala OK
    Pharmazie; 1988 Mar; 43(3):188-90. PubMed ID: 3380861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilized compressed nitroglycerin tablets.
    Goodhart FW; Gucluyildiz H; Daly RE; Chafetz L; Ninger FC
    J Pharm Sci; 1976 Oct; 65(10):1466-71. PubMed ID: 824435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.
    Gryczke A; Schminke S; Maniruzzaman M; Beck J; Douroumis D
    Colloids Surf B Biointerfaces; 2011 Sep; 86(2):275-84. PubMed ID: 21592751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer sorption of nitroglycerin and stability of molded nitroglycerin tablets in unit-dose packaging.
    Pikal MJ; Bibler DA; Rutherford B
    J Pharm Sci; 1977 Sep; 66(9):1293-7. PubMed ID: 409834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
    Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
    Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual nitroglycerin. I. Comparative evaluation of the physical stability of commercially available tablets.
    Lagas M; Duchateau AM
    Pharm Weekbl Sci; 1988 Dec; 10(6):246-53. PubMed ID: 3145487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitroglycerin sublingual tablets. II. Preparation and stability of a new, stabilized, sublingual, molded nitroglycerin tablet.
    Fusari SA
    J Pharm Sci; 1973 Dec; 62(12):2012-21. PubMed ID: 4202680
    [No Abstract]   [Full Text] [Related]  

  • 16. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast disintegrating tablets containing Rhodiola rosea L. extract.
    Kucinskaite A; Sawicki W; Briedis V; Sznitowska M
    Acta Pol Pharm; 2007; 64(1):63-7. PubMed ID: 17665852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Kollidon VA
    Chaudhary RS; Patel C; Sevak V; Chan M
    Drug Dev Ind Pharm; 2018 Jan; 44(1):19-29. PubMed ID: 28832224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.